Are All New-Generation Drug-Eluting Stents Equal? ― Long-Term Follow-up Is Necessary ―
Author:
Affiliation:
1. Division of Cardiology, Mitsui Memorial Hospital
Publisher
Japanese Circulation Society
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://www.jstage.jst.go.jp/article/circj/82/6/82_CJ-18-0331/_pdf
Reference15 articles.
1. 1. Park KW, Rhee TM, Kang HJ, Koo BK, Gwon HC, Yoon JH, et al. Randomized prospective comparison of everolimus-eluting vs. sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: 3-year clinical outcomes of the EXCELLENT randomized trial. Circ J 2018; 82: 1566–1574.
2. 2. Aoki J, Kozuma K, Awata M, Nanasato M, Shiode N, Tanabe K, et al. Five-year clinical outcomes of everolimus-eluting stents from the post marketing tudy of CoCr-EES (XIENCE V/PROMUS) in Japan. Cardiovasc Interv Ther 2018 (in press).
3. 3. Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K, et al. Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: Final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial. Circ Cardiovasc Interv 2014; 7: 343–354.
4. 4. Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, et al. Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2015; 65: 2496–2507.
5. 5. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 2011; 123: 1400–1409.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High-strain-rate superplasticity and tensile behavior of fine-grained Mg97Zn1Y2 alloys fabricated by chip/ribbon-consolidation;Materials Science and Engineering: A;2019-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3